Synapse - Works

Results (2969)

Direct visualization of circulating sarcoma cells by whole-blood fluoresence in situ hybridization

Meeting Abstract

Morozov, A.; Leversha, M.; Keohan, M.; D'Adamo, D. R.; Schwartz, G. K.; Meyers, P. A.; Maki, R. G.; Moore, M. A.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Methotrexate (M) area under the curve (AUC) and creatinine clearance (CrCl) as prognostic factors in primary central nervous system lymphoma (PCNSL)

Meeting Abstract

Morris, P. G.; Abrey, L. E.; Reiner, A. S.; Panageas, K.; Seko, B.; DeAngelis, L. M.; Omuro, A. M.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

T-cell monomorphic post-transplant lymphoproliferative disorders (T-cell m-PTLD): Clinical characteristics and prognostic assessment of a serious complication after transplant

Meeting Abstract

Montanari, F.; Bhagat, G.; Zain, J. M.; Seshan, V. E.; Diefenbach, C. S. M.; Clark-Garvey, S.; McCormick, E.; Crook, M.; Conroy, M.; O'Connor, O.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

HE3235, a synthetic adrenal hormone disease-modifying agent, in castrate resistant prostate cancer (CRPC): Results of phase I/II clinical trial

Meeting Abstract

Montgomery, R. B.; Morris, M. J.; Ryan, C. J.; Stickney, D. R.; Frincke, J. M.; Reading, C. L.; Sarantopoulos, J.; Scher, H. I.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Fluorodeoxyglycose (FDG) PET as an outcome measure for metastatic prostate cancer

Meeting Abstract

Morris, M. J.; Fox, J. J.; Dennis, E. R.; Tse, K.; Flatts, E.; Heller, G.; Jia, X.; Schoder, H.; Larson, S. M.; Scher, H. I.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Correlative biomarkers in a phase II study of dasatinib (D) and weekly (w) paclitaxel (P) for patients (Pts) with metastatic breast carcinoma (MBC)

Meeting Abstract

Morris, P. G.; Chang, J. C.; Abbruzzi, A.; Patil, S.; Modi, S.; Seidman, A. D.; Sklarin, N. T.; Norton, L.; Hudis, C.; Fornier, M. N.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Reactivation of chronic hepatitis B virus in cancer patients receiving immunosuppression: The case for screening

Meeting Abstract

Mendelsohn, R. B.; Nagula, S.; Taur, Y.; Kamboj, M.; Sepkowitz, K.; Zelenetz, A. D.; Ludwig, E.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Phase III intergroup study of lenalidomide versus placebo maintenance therapy following single autologous stem cell transplant (ASCT) for multiple myeloma (MM): CALGB 100104

Meeting Abstract

McCarthy, P. L.; Owzar, K.; Anderson, K. C.; Hofmeister, C. C.; Hassoun, H.; Hurd, D. D.; Stadtmauer, E. A.; Giralt, S.; Hars, V.; Linker, C. A.; more...
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Circulating tumor cells (CTC) and circulating endothelial cells (CEC) in patients (pts) receiving adjuvant bevacizumab (B) plus dose-dense (dd) doxorubicin/cyclophosphamide (AC) followed by nab-paclitaxel (nab-P) for early-stage breast cancer (ESBC)

Meeting Abstract

Melisko, M. E.; Greenberg, S.; Dickler, M. N.; Moasser, M. M.; Scott, J. H.; DeLuca, A. N.; Moore, D. H.; Hudis, C.; Park, J. W.; Rugo, H. S.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save

Lexatumumab: Results of phase I trial in pediatric patients with advanced solid tumors

Meeting Abstract

Merchant, M. S.; Chou, A. J.; Price, A.; Geller, J. I.; Tsokos, M.; Graham, C.; Charles, A.; Meyers, P. A.; Mackall, C.
Journal of Clinical Oncology (2010)

Fulltext@MSK | Save